Literature DB >> 10822530

A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone.

M Wang1, X Xia, Y Kim, D Hwang, J M Jansen, M Botta, D C Liotta, J P Snyder.   

Abstract

[formula: see text] Paclitaxel and epothilone represent the two major classes of antimicrotubule agents that promote tubulin polymerization and, presumably, mitotic arrest during cell division. A common minireceptor binding site model at beta-tubulin has been constructed for these structurally divergent compounds. Utilizing 20 amino acids identified in photoaffinity labeling experiments, the 3-D model correlates measured and predicted Ki's with r = 0.99 and rms(delta Gcalc-delta Gexp) = 0.2 kcal/mol. In addition, the model predicts the affinity of compounds not used in the training set and explains much of the SAR for the paclitaxel and epothilone families.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10822530     DOI: 10.1021/ol990521v

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  10 in total

1.  Nanomolar concentrations of epothilone D inhibit the proliferation of glioma cells and severely affect their tubulin cytoskeleton.

Authors:  A Dietzmann; D Kanakis; E Kirches; S Kropf; C Mawrin; K Dietzmann
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

2.  Evaluation of the tubulin-bound paclitaxel conformation: synthesis, biology, and SAR studies of C-4 to C-3' bridged paclitaxel analogues.

Authors:  Thota Ganesh; Chao Yang; Andrew Norris; Tom Glass; Susan Bane; Rudravajhala Ravindra; Abhijit Banerjee; Belhu Metaferia; Shala L Thomas; Paraskevi Giannakakou; Ana A Alcaraz; Ami S Lakdawala; James P Snyder; David G I Kingston
Journal:  J Med Chem       Date:  2007-01-31       Impact factor: 7.446

3.  C6-C8 bridged epothilones: consequences of installing a conformational lock at the edge of the macrocycle.

Authors:  Weiqiang Zhan; Yi Jiang; Shubhada Sharma; Peggy J Brodie; Susan Bane; David G I Kingston; Dennis C Liotta; James P Snyder
Journal:  Chemistry       Date:  2011-11-30       Impact factor: 5.236

Review 4.  Epothilones: From discovery to clinical trials.

Authors:  Stefano Forli
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

5.  Novel epothilone lactones by an unusual diversion of the Grubbs' metathesis reaction.

Authors:  Qiao-Hong Chen; Thota Ganesh; Yi Jiang; Abhijit Banerjee; Shubhada Sharma; Susan Bane; James P Snyder; David G I Kingston
Journal:  Chem Commun (Camb)       Date:  2010-02-09       Impact factor: 6.222

Review 6.  Epothilones: tubulin polymerization as a novel target for prostate cancer therapy.

Authors:  James J Lee; W Kevin Kelly
Journal:  Nat Clin Pract Oncol       Date:  2008-12-02

7.  Total synthesis and evaluation of 22-(3-azidobenzoyloxy)methyl epothilone C for photoaffinity labeling of beta-tubulin.

Authors:  Oliver E Hutt; Jun Inagaki; Bollu S Reddy; Sajiv K Nair; Emily A Reiff; John T Henri; Jack F Greiner; David G VanderVelde; Ting-Lan Chiu; Elizabeth A Amin; Richard H Himes; Gunda I Georg
Journal:  Bioorg Med Chem Lett       Date:  2009-04-22       Impact factor: 2.823

8.  The bioactive Taxol conformation on beta-tubulin: experimental evidence from highly active constrained analogs.

Authors:  Thota Ganesh; Rebecca C Guza; Susan Bane; Rudravajhala Ravindra; Natasha Shanker; Ami S Lakdawala; James P Snyder; David G I Kingston
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

9.  Design, synthesis and biological evaluation of bridged epothilone D analogues.

Authors:  Qiao-Hong Chen; Thota Ganesh; Peggy Brodie; Carla Slebodnick; Yi Jiang; Abhijit Banerjee; Susan Bane; James P Snyder; David G I Kingston
Journal:  Org Biomol Chem       Date:  2008-11-06       Impact factor: 3.876

10.  De(side chain) model of epothilone: bioconformer interconversions DFT study.

Authors:  Danuta Rusinska-Roszak; Marek Lozynski
Journal:  J Mol Model       Date:  2009-01-20       Impact factor: 1.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.